Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.
Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.
Adaptimmune治疗公司股价上涨，此前该公司公布了好于预期的第二季度每股收益业绩，并重申了指导意见。
Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.
Adaptimmune治疗公司股价上涨，此前该公司公布了好于预期的第二季度每股收益业绩，并重申了指导意见。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。